1. Home
  2. HQY vs BIO Comparison

HQY vs BIO Comparison

Compare HQY & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HQY
  • BIO
  • Stock Information
  • Founded
  • HQY 2002
  • BIO 1952
  • Country
  • HQY United States
  • BIO United States
  • Employees
  • HQY 3120
  • BIO N/A
  • Industry
  • HQY Business Services
  • BIO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • HQY Consumer Discretionary
  • BIO Industrials
  • Exchange
  • HQY Nasdaq
  • BIO Nasdaq
  • Market Cap
  • HQY 7.9B
  • BIO 6.6B
  • IPO Year
  • HQY 2014
  • BIO N/A
  • Fundamental
  • Price
  • HQY $90.95
  • BIO $264.68
  • Analyst Decision
  • HQY Strong Buy
  • BIO Strong Buy
  • Analyst Count
  • HQY 12
  • BIO 4
  • Target Price
  • HQY $117.42
  • BIO $333.50
  • AVG Volume (30 Days)
  • HQY 904.0K
  • BIO 341.7K
  • Earning Date
  • HQY 09-02-2025
  • BIO 07-31-2025
  • Dividend Yield
  • HQY N/A
  • BIO N/A
  • EPS Growth
  • HQY 48.80
  • BIO N/A
  • EPS
  • HQY 1.37
  • BIO 11.49
  • Revenue
  • HQY $1,243,021,000.00
  • BIO $2,554,200,000.00
  • Revenue This Year
  • HQY $9.69
  • BIO N/A
  • Revenue Next Year
  • HQY $8.89
  • BIO $3.42
  • P/E Ratio
  • HQY $66.49
  • BIO $23.00
  • Revenue Growth
  • HQY 19.21
  • BIO N/A
  • 52 Week Low
  • HQY $65.01
  • BIO $211.43
  • 52 Week High
  • HQY $116.65
  • BIO $387.99
  • Technical
  • Relative Strength Index (RSI)
  • HQY 35.51
  • BIO 54.74
  • Support Level
  • HQY $89.81
  • BIO $268.39
  • Resistance Level
  • HQY $99.82
  • BIO $291.87
  • Average True Range (ATR)
  • HQY 2.54
  • BIO 9.60
  • MACD
  • HQY -0.54
  • BIO 1.26
  • Stochastic Oscillator
  • HQY 10.44
  • BIO 47.35

About HQY HealthEquity Inc.

HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: